» Articles » PMID: 36700398

Duality of Nrf2 in Iron-overload Cardiomyopathy

Abstract

Cardiomyopathy deeply affects quality of life and mortality of patients with b-thalassemia or with transfusion-dependent myelodysplastic syndromes. Recently, a link between Nrf2 activity and iron metabolism has been reported in liver ironoverload murine models. Here, we studied C57B6 mice as healthy control and nuclear erythroid factor-2 knockout (Nrf2-/-) male mice aged 4 and 12 months. Eleven-month-old wild-type and Nrf2-/- mice were fed with either standard diet or a diet containing 2.5% carbonyl-iron (iron overload [IO]) for 4 weeks. We show that Nrf2-/- mice develop an age-dependent cardiomyopathy, characterized by severe oxidation, degradation of SERCA2A and iron accumulation. This was associated with local hepcidin expression and increased serum non-transferrin-bound iron, which promotes maladaptive cardiac remodeling and interstitial fibrosis related to overactivation of the TGF-b pathway. When mice were exposed to IO diet, the absence of Nrf2 was paradoxically protective against further heart iron accumulation. Indeed, the combination of prolonged oxidation and the burst induced by IO diet resulted in activation of the unfolded protein response (UPR) system, which in turn promotes hepcidin expression independently from heart iron accumulation. In the heart of Hbbth3/+ mice, a model of b-thalassemia intermedia, despite the activation of Nrf2 pathway, we found severe protein oxidation, activation of UPR system and cardiac fibrosis independently from heart iron content. We describe the dual role of Nrf2 when aging is combined with IO and its novel interrelation with UPR system to ensure cell survival. We open a new perspective for early and intense treatment of cardiomyopathy in patients with b-thalassemia before the appearance of heart iron accumulation.

Citing Articles

Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside.

Dong Y, Zheng M, Ding W, Guan H, Xiao J, Li F Redox Biol. 2025; 81:103551.

PMID: 39965404 PMC: 11876910. DOI: 10.1016/j.redox.2025.103551.


Cardiac injury caused by iron overload in thalassemia.

Fu C, Yang X Front Pediatr. 2025; 13:1514722.

PMID: 39931654 PMC: 11808023. DOI: 10.3389/fped.2025.1514722.


Dimethyl Fumarate Prevents the Development of Chronic Social Stress-Induced Hypertension in Borderline Hypertensive Rats.

Kluknavsky M, Balis P, Liskova S, Micurova A, Skratek M, Manka J Antioxidants (Basel). 2024; 13(8).

PMID: 39199192 PMC: 11351876. DOI: 10.3390/antiox13080947.


Iron Dysregulation in Cardiovascular Diseases.

Wang H, Huang Z, Du C, Dong M Rev Cardiovasc Med. 2024; 25(1):16.

PMID: 39077672 PMC: 11263000. DOI: 10.31083/j.rcm2501016.


n-3 polyunsaturated fatty acids delay intervertebral disc degeneration by inhibiting nuclear receptor coactivator 4-mediated iron overload.

Ao X, Jiang T, Li Y, Lai W, Lian Z, Wang L iScience. 2024; 27(2):108721.

PMID: 38303704 PMC: 10830877. DOI: 10.1016/j.isci.2023.108721.


References
1.
Matte A, Recchiuti A, Federti E, Koehl B, Mintz T, El Nemer W . Resolution of sickle cell disease-associated inflammation and tissue damage with 17-resolvin D1. Blood. 2018; 133(3):252-265. PMC: 6337877. DOI: 10.1182/blood-2018-07-865378. View

2.
Schnelle M, Catibog N, Zhang M, Nabeebaccus A, Anderson G, Richards D . Echocardiographic evaluation of diastolic function in mouse models of heart disease. J Mol Cell Cardiol. 2017; 114:20-28. PMC: 5807035. DOI: 10.1016/j.yjmcc.2017.10.006. View

3.
van Breda G, Bongartz L, Zhuang W, van Swelm R, Pertijs J, Braam B . Cardiac Hepcidin Expression Associates with Injury Independent of Iron. Am J Nephrol. 2016; 44(5):368-378. PMC: 5296884. DOI: 10.1159/000449419. View

4.
Chinprateep B, Ratanasit N, Kaolawanich Y, Karaketklang K, Saiviroonporn P, Viprakasit V . Prevalence of left ventricular diastolic dysfunction by cardiac magnetic resonance imaging in thalassemia major patients with normal left ventricular systolic function. BMC Cardiovasc Disord. 2019; 19(1):245. PMC: 6833207. DOI: 10.1186/s12872-019-1235-8. View

5.
Roczkowsky A, Chan B, Lee T, Mahmud Z, Hartley B, Julien O . Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury. Cardiovasc Res. 2019; 116(5):1021-1031. DOI: 10.1093/cvr/cvz207. View